EcoID is a study designed as an adaptive controlled clinical trial with a first phase of superiority and a second phase of non-inferiority with change of control, of parallel groups, random assignment and blinding of investigators measuring outcome.
Methodology: Methods, techniques and tools provided. Describe the design, study population, materials, procedures and analysis plan: EcoID is a study designed as an adaptive controlled clinical trial with a first phase of superiority and a second phase of non-inferiority with change of control, of parallel groups, random assignment and blinding of investigators measuring outcome. A Bayesian statistical approach will be used for the analysis and inferences of the information obtained from the clinical trial. The use of an adaptive study is justified given that there is uncertainty if the sequential strategy is superior to palpation, so performing the sequential experiment optimizes sample collection. In case the intervention does not pass phase 1, it is not necessary to expose more patients to compare the intervention by the second control. By using a Bayesian statistical approach, it is possible to use the phase 1 sample as a prior probability distribution. Therefore, the adaptive sample of phase 2 is optimized, achieving the best statistical performance with the least amount of time and resources, benefits found in this type of design The study population will be adult patients of the IPS Universitaria, who accept participation in the study and sign the informed consent. In phase 1 of the study, a comparison will be made between identification of the MCT by palpation and the intervention of identification by the sequential strategy of palpation plus ultrasound, this consists of an assessment by palpation and in the event that the participant is not sure in the identification advances in ultrasound assessment. A sample of 129 patients is calculated for each arm. The superiority of the intervention over palpatory control will be assessed, only if this superiority is demonstrated will advance to phase 2. For phase 2, a comparison will be made between identification of the MCT by routine ultrasound and the intervention of identification by the strategy sequential palpation plus ultrasound. The sample will be calculated based on the results of the first phase, the hypothesis will be to demonstrate that this intervention strategy is not inferior to routine ultrasound. The accuracy of the controls and the intervention will be compared against the ultrasound identification of an airway expert with a CUSUM curve greater than 90%. Materials: * Training activities both in MCT identification strategy by palpation with the laryngeal handshake technique, routine ultrasound to achieve a CUSUM curve \> 80% in the participants and training in the sequential strategy. * Mindray M9 ultrasound scanner with linear probe without needle * Yelco gel -Chronometer * UV visible ink marker -Black ink marker
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Enrollment
258
Information alredy included
Information alredy included
Information alredy included
Antioquia´s University
Medellín, Colombia
Proportion of adequate cricothyroid membrane identification by group
Adequate Identification of the cricothyroid membrane For the present study, it is defined as the concordance between the marking performed by any of the interventions and the marking performed by an expert. This must have a distance of less than 5 mm both in the axial and longitudinal planes. An expert in the field is defined as a professional who works using advanced airway management strategies, and has published on airway ultrasonography and/or performs a CUSUM curve for MCT identification \>90%.
Time frame: through study completion, an average of 30 minutes
Degree of difficulty
perceived by evaluators in the identification of the cricothyroid membrane: It is understood as the perception of difficulty of each intervention by the administrators of the intervention.
Time frame: 30 minutes
Time to detection
Defined as the time from the first contact with the patient by the administrator of the intervention, until the marking of the cricothyroid membrane with any of the interventions
Time frame: through study completion, an average of 10 minutes
Longitudinal deviation
Defined as the distance in millimeters between the marking made by the administrator of the intervention and the expert evaluator of the outcome in the lateral plane.
Time frame: through study completion, an average of 10 minutes
Lateral deviation in mm
Defined as the distance in millimeters between the marking made by the administrator of the intervention and the expert evaluator of the outcome in the lateral plane.
Time frame: through study completion, an average of 10 minutes
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Participant satisfaction
Defined as the patients' global perception of satisfaction with the technique. For this measurement, a global Likert-type scale will be used, whose score ranges between 1 and 7, with 1 being very dissatisfied and 7 being very satisfied.
Time frame: through study completion, an average of 10 minutes
Satisfaction of the administrators of the intervention
Defined as the global perception of satisfaction with the technique by the participants administering the intervention. For this measurement, a global Likert-type scale will be used, whose score ranges between 1 and 7, with 1 being very dissatisfied and 7 being very satisfied.
Time frame: through study completion, an average of 10 minutes
Perception of adherence to the technique
Defined as the global perception of future use of the technique by the administrators of the intervention. For this measurement, a Likert-type global scale will be used, whose score ranges between 1 and 7, with 1 being a very poor perception of use in the future and 7 being a very high perception of use in the future
Time frame: through study completion, an average of 10 minutes